A direct look at the dysfunction and pathology of the β cells in human type 2 diabetes.

Beta cell mass Beta cells De-differentiation Inflammation Insulin secretion Pancreatic islets Type 2 diabetes

Journal

Seminars in cell & developmental biology
ISSN: 1096-3634
Titre abrégé: Semin Cell Dev Biol
Pays: England
ID NLM: 9607332

Informations de publication

Date de publication:
07 2020
Historique:
received: 24 01 2020
revised: 27 03 2020
accepted: 09 04 2020
pubmed: 18 5 2020
medline: 25 6 2021
entrez: 18 5 2020
Statut: ppublish

Résumé

β cells uniquely produce and secrete insulin under the control of several, integrated signals, to maintain blood glucose concentrations within a narrow physiological interval. β cell failure is key to the onset and progression of type 2 diabetes, due to impaired function and reduced mass. In this review we focus on several features of human β cell dysfunction and pathology in type 2 diabetes, as revealed by direct assessment of isolated islet traits and examination of pancreatic tissue from organ donors, surgical samples or autoptic specimens. Insulin secretion defects and pathology findings are discussed in relation to some of the major underlying mechanisms, to also provide clues for conceiving better prevention and treatment of type 2 diabetes by targeting the pancreatic β cells.

Identifiants

pubmed: 32417220
pii: S1084-9521(19)30053-9
doi: 10.1016/j.semcdb.2020.04.005
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

83-93

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Piero Marchetti (P)

Department of Clinical and Experimental Medicine - University of Pisa, Via Savi 10, Pisa, Italy. Electronic address: piero.marchetti@med.unipi.it.

Mara Suleiman (M)

Department of Clinical and Experimental Medicine - University of Pisa, Via Savi 10, Pisa, Italy.

Carmela De Luca (C)

Department of Clinical and Experimental Medicine - University of Pisa, Via Savi 10, Pisa, Italy.

Walter Baronti (W)

Department of Clinical and Experimental Medicine - University of Pisa, Via Savi 10, Pisa, Italy.

Emanuele Bosi (E)

Department of Clinical and Experimental Medicine - University of Pisa, Via Savi 10, Pisa, Italy.

Marta Tesi (M)

Department of Clinical and Experimental Medicine - University of Pisa, Via Savi 10, Pisa, Italy.

Lorella Marselli (L)

Department of Clinical and Experimental Medicine - University of Pisa, Via Savi 10, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH